NOVIJOINT
LIVE

Serial Number

99510025

Owner

Fulcrum Health Ltd.

Attorney

Rhett V. Barney

Filing Date

Nov 21, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NOVIJOINT Trademark

Serial Number: 99510025

NOVIJOINT is a trademark filed by Fulcrum Health Ltd. on November 21, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Fulcrum Health Ltd.

6 Nene Road, Bicton Industrial Estate
Kimbolton PE280LF , GB

Entity Type: 16

Trademark Details

Filing Date

November 21, 2025

Registration Date

Not Registered

Goods & Services

Dietary supplemental drinks in the nature of vitamin and mineral beverages; Vitamin supplements; Vitamin C preparations; Vitamin and mineral supplements; Vitamin enriched water for medical purposes; Powdered nutritional supplement drink mix containing Hyaluronic Acid and Vitamin C; Vitamin and mineral preparations for medical use; Dietetic beverages for treating Musculo-skeletal disorders; Vitamin fortified beverages for medical purposes; Hyaluronic acid for pharmaceutical purposes; Nutritional supplements for Musculo-skeletal disorders; Nutritionally fortified beverages for medical purposes; Nutritional supplements in the form of liquids; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Anti-inflammatory preparations; Anti-inflammatories; Analgesic and anti-inflammatory preparations; Preparation for the relief of pain; Pain relief medication; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of rheumatological discomfort and pain; Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical preparations, namely, elixirs for the treatment of Musculo-skeletal disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical products for the treatment of bone diseases; Skeletal muscle relaxants; Muscle relaxants; Medicaments to help assist with the regeneration of ligament and tendon fibers; Medicaments for tendon, bone, cartilage and muscle injuries; Beverages containing Hyaluronic Acid and Vitamin C for use as a nutritional supplement

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 12, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 12, 2026 GNSL
SUSPENSION LETTER WRITTEN
Mar 12, 2026 CNSL
ASSIGNED TO EXAMINER
Mar 12, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2025 NWOS
NEW APPLICATION ENTERED
Nov 21, 2025 NWAP